References
Bournia VK, Vlachoyiannopoulos PG. Subgroups of Sjögren syndrome patients according to serological profiles. J Autoimmun. 2012;39(1–2):15–26. https://doi.org/10.1016/j.jaut.2012.03.001.
Mavragani CP, Moutsopoulos HM. The geoepidemiology of Sjögren’s syndrome. Autoimmun Rev. 2010;9(5):A305–10. https://doi.org/10.1016/j.autrev.2009.11.004.
Al-Hashimi I, Khuder S, Haghighat N, Zipp M. Frequency and predictive value of the clinical manifestations in Sjögren’s syndrome. J Oral Pathol Med. 2001;30(1):1–6. https://doi.org/10.1034/j.1600-0714.2001.300101.x.
Kruszka P, O’Brian RJ. Diagnosis and management of Sjögren syndrome. Am Fam Physician. 2009;79(6):465–70.
Gono T. Clinical manifestations of neurological involvement in primary Sjögren’s syndrome. Clin Rheumatol. 2011;30(4):485–90. https://doi.org/10.1007/s10067-010-1458-7.
Berkowitz AL, Samuels MA. The neurology of Sjogren’s syndrome and the rheumatology of peripheral neuropathy and myelitis. Pract Neurol. 2014;14(1):14–22. https://doi.org/10.1136/practneurol-2013-000651.
Azhary H, Farooq MU, Bhanushali M, Majid A, Kassab MY. Peripheral neuropathy: differential diagnosis and management. Am Fam Physician. 2010;81(7):887–92.
Johnsen B, Fuglsang-Frederiksen A. Electrodiagnosis of polyneuropathy. Neurophysiol Clin Clin Neurophysiol. 2000;30(6):339–51. https://doi.org/10.1016/S0987-7053(00)00237-9.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Weisman MH. Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8. https://doi.org/10.1136/ard.61.6.554.
Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sjögren’s syndrome: a data-driven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance Cohort. Arthritis Care Res. 2012;64(4):475–87. https://doi.org/10.1002/acr.21591.
Aletaha D, Neogi T, Silman AJ, Funovits J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria. Arthritis Rheum. 2010;62(9):2569–81. https://doi.org/10.1002/art.27584.
Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7. https://doi.org/10.1002/art.1780251101.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. https://doi.org/10.1002/art.1780400928.
Jennette JC. Nomenclature and classification of vasculitis: lessons learned from granulomatosis with polyangiitis (Wegener’s granulomatosis). Clin Exp Immunol. 2011;164:7–10. https://doi.org/10.1111/j.1365-2249.2011.04357.x.
Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia. 2009;23(1):3–9. https://doi.org/10.1038/leu.2008.291.
Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302. https://doi.org/10.1002/ana.22366.
Chauvin S, Sobel A. Neuronal stathmins: a family of phosphoproteins cooperating for neuronal development, plasticity and regeneration. Prog Neurobiol. 2015;126:1–18. https://doi.org/10.1016/j.pneurobio.2014.09.002.
Gavet O, El Messari S, Ozon S, Sobel A. Regulation and subcellular localization of the microtubule-destabilizing stathmin family phosphoproteins in cortical neurons. J Neurosci Res. 2002;68(5):535–50. https://doi.org/10.1002/jnr.10234.
Liedtke W, Leman EE, Fyffe REW, Raine CS, Schubart UK. Stathmin-deficient mice develop an age-dependent axonopathy of the central and peripheral nervous systems. Am J Pathol. 2002;160(2):469–80. https://doi.org/10.1016/S0002-9440(10)64866-3.
Acknowledgements
The authors would like to thank Dr. Manoj B Menon for his expertise in infrared imaging using Li-cor scanner and the Institute of Physiological Chemistry, Hannover Medical University, Carl-Neuberg-Str.1, Hannover 30625, Germany.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the ethical committee of the Medical School Hannover (project number 4928), and the patients provided informed consent. Research was carried out on humans in compliance with the Helsinki Declaration.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Duda, S., Witte, T., Stangel, M. et al. Autoantibodies binding to stathmin-4: new marker for polyneuropathy in primary Sjögren’s syndrome. Immunol Res 65, 1099–1102 (2017). https://doi.org/10.1007/s12026-017-8970-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-017-8970-7